StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
2534
This month
2
This week
1
This year
722
Yesterday
1
Publishing Date
2023 - 11 - 27
8
2023 - 10 - 25
11
2023 - 10 - 12
9
2023 - 07 - 17
10
2023 - 07 - 11
8
2023 - 06 - 28
9
2023 - 05 - 09
11
2023 - 03 - 28
10
2023 - 03 - 23
8
2023 - 02 - 28
8
2023 - 02 - 22
9
2022 - 06 - 21
8
2022 - 05 - 24
12
2022 - 05 - 18
8
2022 - 05 - 09
9
2022 - 03 - 16
10
2022 - 02 - 28
8
2022 - 02 - 24
10
2022 - 01 - 05
11
2021 - 12 - 07
8
2021 - 11 - 30
8
2021 - 11 - 18
7
2021 - 11 - 16
7
2021 - 11 - 11
11
2021 - 11 - 03
7
2021 - 11 - 02
7
2021 - 10 - 25
7
2021 - 10 - 19
9
2021 - 10 - 18
7
2021 - 10 - 12
8
2021 - 10 - 04
8
2021 - 09 - 27
7
2021 - 09 - 22
7
2021 - 09 - 09
7
2021 - 08 - 24
7
2021 - 08 - 23
9
2021 - 08 - 17
7
2021 - 08 - 05
7
2021 - 07 - 29
9
2021 - 07 - 27
9
2021 - 07 - 26
7
2021 - 07 - 22
9
2021 - 07 - 07
7
2021 - 07 - 01
7
2021 - 06 - 30
7
2021 - 06 - 24
9
2021 - 06 - 22
10
2021 - 06 - 17
8
2021 - 06 - 16
10
2021 - 06 - 10
7
2021 - 06 - 08
7
2021 - 05 - 24
10
2021 - 05 - 17
8
2021 - 05 - 03
8
2021 - 04 - 13
9
2021 - 04 - 08
8
2021 - 02 - 26
9
2021 - 02 - 22
9
2021 - 02 - 08
9
2021 - 01 - 11
7
Sector
Commercial services
44
Communications
20
Construction
2
Consumer durables
3
Consumer non-durables
15
Consumer services
2
Distribution services
2
Electronic technology
9
Energy minerals
12
Finance
12
Finance and insurance
5
Health care and social assistance
12
Health services
86
Health technology
1996
Industrial services
3
Information
1
Manufacturing
151
Mining, quarrying, and oil and gas extraction
13
Miscellaneous
2
N/a
62
Process industries
13
Producer manufacturing
6
Professional, scientific, and technical services
124
Real estate and rental and leasing
1
Retail trade
7
Technology services
27
Transportation
1
Utilities
2
Tags
Acquisition
7848
Agreement
2536
Application
2265
Approval
2283
Business
3448
Cancer
3996
Ceo
2400
Ces
2927
Collaboration
2243
Conference
21628
Corporation
5015
Covid
2710
Deadline
3773
Disease
2534
Distribution
2875
Drug
2606
Earnings
3571
Energy
7181
Europe
2290
Events
4709
Fda
3251
Financial
13094
Financial results
8251
Global
10240
Group
4463
Growth
12111
Health
4716
International
2055
Management
2395
Market
21565
Media
2136
Meeting
3058
N/a
264949
Nasdaq
3478
Offering
6918
Partnership
2588
People
2345
Pharma
2252
Pharmaceuticals
2375
Platform
2160
Positive
2825
Presentation
2958
Program
3553
Report
14179
Research
9877
Results
38985
Sales
2113
Services
2701
Solutions
2392
Spac
2298
Study
2254
System
2447
Technology
6301
Test
2331
Therapeutics
8462
Therapy
2764
Treatment
4943
Trial
6681
Update
4356
Year
4854
Entities
Abbott laboratories
61
Abbvie inc.
60
Ac immune sa
20
Acadia pharmaceuticals inc.
12
Acumen pharmaceuticals inc
13
Adaptive biotechnologies corporation
12
Aldeyra therapeutics, inc.
17
Alterity therapeutics limited
12
Amgen inc.
24
Amicus therapeutics, inc.
20
Anavex life sciences corp.
23
Annovis bio, inc.
26
Astellas pharma inc
14
Astrazeneca plc
32
Athira pharma, inc.
21
Bausch health companies inc.
20
Beam therapeutics inc.
15
Becton, dickinson and company
21
Bio-rad laboratories, inc.
15
Biogen inc.
67
Biovie inc.
31
Boston scientific corporation
16
Bridgebio pharma, inc.
14
Bristol-myers squibb company
20
Cassava sciences, inc.
25
Centogene n.v.
21
Chinook therapeutics, inc.
12
Cognition therapeutics inc
19
Cyclo therapeutics inc - class a
17
Danaher corporation
17
Denali therapeutics inc.
12
Editas medicine, inc.
12
Eli lilly and company
82
Gain therapeutics inc
15
Gilead sciences, inc.
19
Glaxosmithkline plc
36
Global blood therapeutics, inc.
33
Horizon therapeutics public limited company
23
Incyte corporation
15
Inhibikase therapeutics, inc.
13
Inmune bio inc.
15
Ionis pharmaceuticals, inc.
14
Jaguar health, inc.
14
Johnson & johnson
97
Koninklijke philips n.v.
15
Medtronic plc
29
Mesoblast limited
20
Novartis ag
69
Novo nordisk a/s
15
Orange
20
Pfizer, inc.
25
Protalix biotherapeutics, inc.
14
Regeneron pharmaceuticals, inc.
16
Regulus therapeutics inc.
21
Sanofi
162
Takeda pharmaceutical company limited
31
Teva pharmaceutical industries ltd
33
Thermo fisher scientific inc
41
Viatris inc.
15
Zyversa therapeutics inc
15
Symbols
ABBV
60
ABOS
13
ABT
61
ACAD
12
ACIU
20
ALDX
17
ALPMF
14
ALPMY
14
AMGN
24
ANVS
26
ATHA
21
AVXL
23
AZN
32
AZNCF
21
BBIO
14
BDX
21
BEAM
15
BHC
20
BIIB
67
BIO
15
BIVI
31
BMY
20
BSX
16
CGTX
19
CNTG
21
CYTH
17
DHR
17
FNCTF
20
FOLD
20
GANX
15
GBT
33
GILD
19
GLAXF
22
GSK
36
HZNP
23
IKT
13
INCY
15
INMB
15
IONS
14
JAGX
14
JNJ
97
LLY
82
MDT
29
MESO
20
NVO
15
NVS
69
NVSEF
54
PFE
25
PHG
15
PLX
14
REGN
16
RGLS
21
SAVA
25
SNY
162
SNYNF
113
TAK
31
TEVJF
33
TMO
41
VTRS
15
ZVSA
15
Exchanges
Amex
71
Lse
25
Nasdaq
2169
Nyse
538
Tsx
4
Crawled Date
2023 - 11 - 27
9
2023 - 10 - 25
12
2023 - 10 - 12
9
2023 - 09 - 07
8
2023 - 07 - 17
10
2023 - 07 - 11
8
2023 - 06 - 28
9
2023 - 05 - 09
11
2023 - 03 - 28
10
2023 - 03 - 06
8
2023 - 02 - 22
9
2023 - 02 - 09
9
2022 - 12 - 15
8
2022 - 10 - 24
8
2022 - 06 - 21
8
2022 - 05 - 24
10
2022 - 05 - 18
8
2022 - 05 - 09
8
2022 - 03 - 16
10
2022 - 03 - 15
8
2022 - 02 - 28
8
2022 - 02 - 24
10
2022 - 01 - 06
10
2021 - 11 - 30
8
2021 - 11 - 11
9
2021 - 10 - 26
7
2021 - 10 - 19
11
2021 - 10 - 12
8
2021 - 10 - 04
8
2021 - 09 - 22
7
2021 - 09 - 09
7
2021 - 08 - 24
7
2021 - 08 - 23
9
2021 - 08 - 17
7
2021 - 08 - 05
7
2021 - 07 - 29
9
2021 - 07 - 27
9
2021 - 07 - 26
7
2021 - 07 - 22
8
2021 - 07 - 07
7
2021 - 07 - 01
8
2021 - 06 - 24
9
2021 - 06 - 22
10
2021 - 06 - 17
8
2021 - 06 - 16
10
2021 - 06 - 10
7
2021 - 06 - 08
7
2021 - 05 - 24
11
2021 - 05 - 17
8
2021 - 05 - 03
8
2021 - 04 - 20
7
2021 - 04 - 13
9
2021 - 04 - 08
8
2021 - 03 - 29
7
2021 - 02 - 26
9
2021 - 02 - 22
9
2021 - 02 - 08
9
2021 - 01 - 11
8
2020 - 12 - 02
9
2020 - 12 - 01
10
Crawled Time
00:00
58
00:20
5
01:00
28
02:00
11
03:00
11
04:00
8
04:20
2
05:00
17
06:00
21
07:00
25
08:00
35
08:20
4
09:00
29
10:00
36
10:13
2
10:41
2
11:00
156
11:03
2
12:00
378
12:01
8
12:02
2
12:03
13
12:04
3
12:15
41
12:20
87
12:25
3
12:30
48
13:00
264
13:01
8
13:03
8
13:04
3
13:05
4
13:15
29
13:20
60
13:30
53
13:47
2
14:00
191
14:01
6
14:02
2
14:08
2
14:15
21
14:20
26
14:27
3
14:30
33
15:00
126
15:01
4
15:15
9
15:20
10
15:30
17
16:00
70
16:20
18
17:00
75
18:00
57
19:00
53
20:00
69
20:20
6
21:00
97
21:03
2
22:00
67
23:00
51
Source
alteritytherapeutics.com
7
alzamend.com
3
brightmindsbio.com
1
contravir.com
2
feed.businesswire.com
2
investor.alkermes.com
2
investors.biomarin.com
2
ionispharma.com
1
ir.akerotx.com
1
ir.biolinerx.com
1
ir.cyclerion.com
5
ir.hoththerapeutics.com
4
ir.plxpharma.com
1
ir.stockpr.com
3
ir.vaccinex.com
6
ir.voyagertherapeutics.com
4
ir.vtvtherapeutics.com
1
jaguarhealth.gcs-web.com
13
neurosense.investorroom.com
1
ocutx.gcs-web.com
2
spacfeed.com
8
www.4dpharmaplc.com
2
www.admabiologics.com
1
www.agtc.com
1
www.anaptysbio.com
1
www.anavex.com
3
www.anpacbio.com
2
www.appliedtherapeutics.com
1
www.athira.com
3
www.biospace.com
1184
www.brainsway.com
3
www.chiasmapharma.com
1
www.clarivate.com
1
www.cortexyme.com
1
www.cyberark.com
1
www.equilliumbio.com
1
www.eyegatepharma.com
1
www.fda.gov
1
www.generationbio.com
1
www.globenewswire.com
723
www.igcinc.us
2
www.igmbio.com
1
www.immunoprecise.com
1
www.inventivapharma.com
2
www.jupiterwellnessinc.com
1
www.limoneira.com
1
www.marronebio.com
1
www.mdc-partners.com
1
www.mednax.com
1
www.nanthealth.com
4
www.nantkwest.com
2
www.natera.com
1
www.pacb.com
2
www.prnewswire.com
489
www.renalytixai.com
2
www.tabularasahealthcare.com
2
www.taylordevices.com
2
www.vynetherapeutics.com
2
www.xortx.com
5
www.zynerba.com
2
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
Disease
save search
Alterity Therapeutics Reports Positive Efficacy Data for ATH434 in a Primate Model of Parkinson’s Disease
Published:
2023-12-03
(Crawled : 00:00)
- alteritytherapeutics.com
ATHE
|
$1.66
-8.29%
0.0%
24K
|
Health Technology
|
Email alert
Add to watchlist
ath434
disease
positive
parkinson’s
therapeutics
Neuromuscular Disease Therapeutics Market size to grow by USD 65.13 billion from 2022-2027| Aquestive Therapeutics Inc., Bausch Health Companies Inc., Biogen Inc. and more among the major companies in the market- Technavio
Published:
2023-12-01
(Crawled : 19:00)
- prnewswire.com
SNYNF
|
$94.0
1.34%
1.34%
860
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
$97.95
1.48%
2.98%
100
|
Health Technology
|
Email alert
Add to watchlist
BHC
|
$7.36
3.08%
0.0%
1.8M
|
Health Technology
|
Email alert
Add to watchlist
BIIB
|
$234.64
0.24%
0.26%
570K
|
Health Technology
|
Email alert
Add to watchlist
SNY
|
$46.72
-0.06%
-0.06%
1.1M
|
Health Technology
|
Email alert
Add to watchlist
BCLI
|
$0.26
-6.81%
-7.31%
3.7M
|
Health Technology
|
Email alert
Add to watchlist
VTRS
|
$9.37
2.07%
1.92%
6.4M
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
$98.13
0.24%
-0.16%
1.2M
|
Health Technology
|
Email alert
Add to watchlist
disease
companies
health
therapeutics
market
Soligenix Receives FDA IND Clearance for Phase 2 Clinical Trial of Dusquetide in the Treatment of Aphthous Ulcers in Behçet's Disease
Published:
2023-11-30
(Crawled : 15:30)
- biospace.com/
SNGX
|
$0.73
75.73%
-5.49%
7M
|
Health Technology
|
32.76%
|
O:
32.76%
H:
0.0%
C:
0.0%
fda
disease
treatment
clearance
trial
Teva Completes Closing of Exclusive Collaboration Deal to Deliver Inflammatory Bowel Disease Treatment
Published:
2023-11-30
(Crawled : 15:00)
- biospace.com/
SNYNF
|
$94.0
1.34%
1.34%
860
|
Health Technology
|
-0.35%
|
O:
-0.35%
H:
0.0%
C:
0.0%
TEVA
|
$9.71
-1.12%
0.0%
6.2M
|
Health Technology
|
1.34%
|
O:
-0.52%
H:
3.73%
C:
1.87%
SNY
|
$46.72
-0.06%
-0.06%
1.1M
|
Health Technology
|
-0.17%
|
O:
-1.09%
H:
0.0%
C:
0.0%
disease
treatment
collaboration
teva
deal
Guardant Health to present data at San Antonio Breast Cancer Symposium demonstrating utility of liquid biopsy in biomarker identification, therapy selection and residual disease detection
Published:
2023-11-30
(Crawled : 15:00)
- biospace.com/
GH
|
$26.33
4.61%
0.61%
1.1M
|
Health Services
|
0.2%
|
O:
1.51%
H:
3.92%
C:
-1.29%
disease
breast
health
symposium
biomarker
cancer
therapy
Edgewise Receives Orphan Drug and Rare Pediatric Disease Designations for Its Muscular Dystrophy Program from FDA
Published:
2023-11-30
(Crawled : 15:00)
- biospace.com/
EWTX
|
$6.19
1.81%
2.01%
900K
|
Manufacturing
|
8.68%
|
O:
8.68%
H:
0.0%
C:
0.0%
fda
rare
drug
disease
program
BioVie Announces Efficacy Data from Phase 3 Trial of NE3107 in Patients with Mild to Moderate Alzheimer’s Disease
Published:
2023-11-29
(Crawled : 13:00)
- globenewswire.com
BIVI
P
|
$1.68
-6.67%
-6.82%
1.3M
|
Health Technology
|
-66.91%
|
O:
-70.4%
H:
0.0%
C:
0.0%
ne3107
disease
alzheimer’s
trial
Cerevel Therapeutics to Host Investor Webcast on Tavapadon in Parkinson’s Disease
Published:
2023-11-29
(Crawled : 12:00)
- globenewswire.com
CERE
|
$26.0
0.27%
-2.0%
1.6M
|
Finance
|
3.43%
|
O:
-0.08%
H:
5.19%
C:
1.2%
disease
parkinson’s
therapeutics
uniQure Announces FDA Clearance of Investigational New Drug Application for AMT-191 Gene Therapy for Fabry Disease
Published:
2023-11-29
(Crawled : 12:00)
- globenewswire.com
QURE
|
$7.14
5.31%
4.84%
740K
|
Health Technology
|
0.3%
|
O:
3.25%
H:
4.58%
C:
-2.58%
amt-191
fda
drug
disease
clearance
application
therapy
Baptist Health Lexington Enhances 20-Year Leadership in Pioneering Advanced Robotic Technology for Heart Disease Patients
Published:
2023-11-28
(Crawled : 14:00)
- globenewswire.com
STXS
|
$1.77
7.27%
0.0%
220K
|
Health Technology
|
Email alert
Add to watchlist
disease
health
heart
technology
Athira Pharma Announces Upcoming Presentation at Motor Neurone Disease Association’s 34ᵗʰ International Symposium on ALS/MND
Published:
2023-11-28
(Crawled : 12:00)
- globenewswire.com
ATHA
|
$1.51
4.86%
4.64%
160K
|
Health Technology
|
-5.88%
|
O:
-2.61%
H:
0.0%
C:
0.0%
pharma
disease
symposium
presentation
international
Aldeyra Therapeutics Receives Complete Response Letter from the U.S. Food and Drug Administration for the Reproxalap New Drug Application for the Treatment of Dry Eye Disease
Published:
2023-11-27
(Crawled : 23:00)
- biospace.com/
ALDX
|
$2.86
3.25%
0.35%
910K
|
Health Technology
|
Email alert
Add to watchlist
reproxalap
drug
disease
food
treatment
eye
application
therapeutics
response
Acadia Pharmaceuticals Initiates Phase 2 Clinical Trial of ACP-204 for the Treatment of Alzheimer’s Disease Psychosis
Published:
2023-11-27
(Crawled : 19:00)
- biospace.com/
ACAD
G
|
$22.6
1.44%
0.0%
1.2M
|
Health Technology
|
Email alert
Add to watchlist
acp-204
disease
alzheimer’s
treatment
pharmaceuticals
trial
INmune Bio Receives EMA’s Authorization in France and Spain for Phase II Clinical Trial of XPro™ for Early Alzheimer’s Disease
Published:
2023-11-27
(Crawled : 13:00)
- globenewswire.com
INMB
|
$9.61
1.69%
-1.67%
57K
|
Health Technology
|
5.23%
|
O:
2.0%
H:
5.24%
C:
2.29%
disease
alzheimer’s
authorization
trial
iCAD’s ProFound AI Can Predict 1-2 Year Risk for Breast Cancer and Reveal Insights for Heart Disease
Published:
2023-11-27
(Crawled : 13:00)
- globenewswire.com
ICAD
|
$1.77
9.94%
-1.13%
220K
|
Technology Services
|
21.51%
|
O:
0.38%
H:
0.0%
C:
0.0%
reveal
disease
breast
year
cancer
risk
heart
Annovis Bio Announces Full Enrollment of Its Phase II/III Alzheimer’s Disease Trial, Exceeding Original Projections
Published:
2023-11-27
(Crawled : 12:30)
- globenewswire.com
ANVS
|
$8.49
1.88%
240K
|
Health Technology
|
26.09%
|
O:
2.56%
H:
17.65%
C:
8.68%
disease
alzheimer’s
Sernova Receives Orphan Drug and Rare Pediatric Disease Designations for its Hemophilia A Program from FDA
Published:
2023-11-27
(Crawled : 12:30)
- globenewswire.com
SEOVF
|
$0.518
-2.23%
39.11%
100K
|
Health Technology
|
Email alert
Add to watchlist
fda
rare
drug
disease
program
Dupixent® (dupilumab) Significantly Reduced COPD Exacerbations in Second Positive Phase 3 Trial, Accelerating FDA Submission and Confirming Potential to Become First Approved Biologic for This Serious Disease
Published:
2023-11-27
(Crawled : 07:00)
- globenewswire.com
SNY
|
$46.72
-0.06%
-0.06%
1.1M
|
Health Technology
|
-1.25%
|
O:
1.04%
H:
0.17%
C:
0.11%
REGN
|
$814.86
-1.09%
0.31%
560K
|
Health Technology
|
3.06%
|
O:
-0.03%
H:
0.37%
C:
-0.49%
dupixent
fda
disease
approved
positive
copd
potential
submission
Press Release: Dupixent® significantly reduced COPD exacerbations in second positive Phase 3 trial, accelerating FDA submission and confirming potential to become first approved biologic for this serious disease
Published:
2023-11-27
(Crawled : 07:00)
- globenewswire.com
SNY
|
$46.72
-0.06%
-0.06%
1.1M
|
Health Technology
|
-1.25%
|
O:
1.04%
H:
0.17%
C:
0.11%
REGN
|
$814.86
-1.09%
0.31%
560K
|
Health Technology
|
3.06%
|
O:
-0.03%
H:
0.37%
C:
-0.49%
dupixent
fda
disease
approved
positive
copd
potential
submission
Mesoblast Files for Orphan Drug and Pediatric Rare Disease Designations for Rexlemestrocel-L as Treatment for Severe Congenital Heart Disease
Published:
2023-11-26
(Crawled : 00:00)
- globenewswire.com
MESO
|
$1.36
-1.45%
-2.94%
0
|
Health Technology
|
4.21%
|
O:
4.21%
H:
2.94%
C:
0.74%
rare
drug
disease
treatment
heart
← Previous
1
2
3
4
5
6
7
8
9
…
126
127
Next →
Gainers vs Losers
77%
23%
Top 10 Gainers
ID
4
|
$0.077
-9.41%
25.97%
420K
|
Finance
BKKT
4
|
$1.88
25.33%
14.89%
4.8M
|
MGLD
|
$1.03
7.77%
14K
|
Manufacturing
CZOO
|
$0.4316
-6.52%
6.7%
65K
|
SATX
|
$0.4226
-1.72%
6.48%
29K
|
n/a
CCJ
|
$45.4
-1.13%
4.6%
3.9M
|
Non-Energy Minerals
AUMN
|
$0.562
0.34%
4.5%
360K
|
Non-Energy Minerals
JBL
|
$116.91
1.38%
4.3%
2M
|
Electronic Technology
SAIC
4
|
$119.92
2.14%
4.24%
460K
|
Technology Services
CULP
4
|
$5.06
-0.59%
3.95%
29K
|
Process Industries
Your saved searches
Save your searches and get alerts when important news are released.